What is ASST's last price and market cap on Chartloom?

The overview shows a last price near n/a and market cap near 2.45B (subject to data latency), alongside the price snapshot and profile on this page.

What P/E and 52-week range are shown for ASST?

P/E (TTM) is n/a and 52-week range is $7.02 to $36.20 when available from the data feed; see the metrics and chart on this page.

Where do Chartloom’s ASST figures come from?

Figures are compiled from market data and SEC-backed fundamentals used in the app. Use primary filings and a broker for trading decisions.

What trailing-twelve-month financials does Chartloom show for ASST?

The company profile lists revenue (TTM) near $9M, net income (TTM) near $-104.04B, EPS (TTM) near $-16.93 when available from the market-data feed. Figures are informational and may lag live markets.

Does ASST show a dividend on Chartloom?

The overview lists dividend per share (TTM) near $0.10 when those figures are present. Dividend history is compiled from vendor data, not a distribution notice.

Where is Strive Inc based, and what identifiers does Chartloom list?

The company context section lists headquarters in Dallas, Texas, US, 84.1M shares outstanding, ISIN US8629453007 when available from company profile and filing metadata.

Please enable JavaScript to continue using this application.

Strive Inc (ASST) Stock Analysis, Quote & Company Profile

Free AI scores & summaries library

Strive Inc

$ASST

Health Care · Health Care Equipment & Supplies

IR Run Scenarios

$24.09

-6.08%

Overview AI Summary Charts Financials Valuation

Profile

Read AI summary

Strive, Inc. engages in the provision of an asset management Bitcoin treasury. The company is headquartered in Dallas, Texas and currently employs 28 full-time employees. The company went IPO on 2023-02-03. The firm is focused on increasing Bitcoin per share to outperform Bitcoin over the long run. The firm's subsidiary, Strive Asset Management, LLC, is a SEC-registered investment adviser, which has assets under management (AUM) across approximately 13 exchange-traded funds, collective investment trusts, and a direct indexing platform. In addition, the Company owns Semler Scientific, Inc., a healthcare technology subsidiary focused on early disease detection products. Through its healthcare businesses, Semler Scientific and its wholly-owned subsidiary, CardioVanta, Inc. develop and market products and services for early detection and monitoring of chronic diseases. Semler Scientific's flagship product, QuantaFlo, provides rapid point-of-care testing to measure arterial blood flow in the extremities. The QuantaFlo test aids in the diagnosis of peripheral arterial disease.

Employees

Website

investors.strive.com/

IPO

2023-02-03

Beta

Next earnings date

—

Financials & valuation

Open valuation

Revenue (TTM)

Net income (TTM)